Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

456.91 -2.87 (-0.62%)

Streaming Delayed Price Updated: 9:50 AM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

69 70 Next >

Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

December 05, 2023

Via Benzinga

Better Growth Stock: CRISPR Therapeutics vs. Invitae ↗

December 05, 2023

One of these stocks may be riskier than the other...

Via The Motley Fool

Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗

December 04, 2023

Via Benzinga

You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. ↗

December 04, 2023

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

Via The Motley Fool

A Bull Market Is Coming. Here Are 3 Stocks You'll Absolutely Want to Own. ↗

December 04, 2023

These stocks are already big winners in 2023 and should keep their momentum going in a new bull market.

Via The Motley Fool

Where Will Vertex Pharmaceuticals Be in 10 Years? ↗

December 04, 2023

Vertex shares have soared 400% over the past decade.

Via The Motley Fool

3 No-Brainer Growth Stocks to Buy in December ↗

December 03, 2023

No analysis paralysis is required with these great stocks.

Via The Motley Fool

Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now ↗

December 03, 2023

The one thing these two stocks have in common is tremendous growth prospects.

Via The Motley Fool

5 Top Stocks to Buy Before 2024 ↗

December 02, 2023

These stocks have room to run -- next year and over the long term.

Via The Motley Fool

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗

December 01, 2023

It's not as long a shot as some might think.

Via The Motley Fool

Looking for Growth? 2 Top Stocks to Buy Hand Over Fist ↗

December 01, 2023

These stocks offer enormous long-term growth potential.

Via The Motley Fool

3 Biotech Stocks That Could Be Multibaggers in the Making ↗

November 30, 2023

Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments.

Via InvestorPlace

3 Top-Rated Biotech Stocks That Analysts Are Loving Now ↗

November 28, 2023

Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.

Via InvestorPlace

Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗

November 27, 2023

We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.

Via Talk Markets

5 Stocks You Can Confidently Invest $500 In Right Now ↗

November 27, 2023

These companies could significantly grow your investment over the long haul.

Via The Motley Fool

2 Healthcare Stocks That Could Help Set You Up for Life ↗

November 25, 2023

Both companies are leaders in their fields.

Via The Motley Fool

Investing in These 3 Stocks Now Could Make You a Millionaire Retiree ↗

November 25, 2023

These innovators should have tremendous long-term growth prospects.

Via The Motley Fool

4 First-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

November 25, 2023

The innovation-fueled Nasdaq Composite is still 11% below its all-time high, which means bargains abound for opportunistic investors.

Via The Motley Fool

Topics Stocks

European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5

November 23, 2023

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Prediction: 3 Stocks That Could Trounce the Market ↗

November 23, 2023

These stocks have what it takes to be huge winners over the next several years.

Via The Motley Fool

3 Biotech Stocks That Could Be Millionaire Makers ↗

November 22, 2023

Many biotech stocks offer exciting long-term growth prospects.

Via The Motley Fool

Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today ↗

November 21, 2023

Via Benzinga

2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street ↗

November 20, 2023

Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio?

Via The Motley Fool

Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire? ↗

November 19, 2023

The stock is trading below its peak, reached a couple of years ago.

Via The Motley Fool

Barron's Weekend Stock Picks: Disney, Palantir And Cisco's Calamitous Outlook ↗

November 18, 2023

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Via Benzinga

Why CRISPR Therapeutics Stock Is Jumping Again Today ↗

November 17, 2023

The stock continues to enjoy momentum from a key regulatory approval.

Via The Motley Fool

Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling ↗

November 17, 2023

The Nasdaq 100 closed higher by 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

InvestorNewsBreaks – Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Featured in Barron’s Article for Potential Near ‘Breakthrough’

November 16, 2023

Via Investor Brand Network

Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug ↗

November 16, 2023

The drug will sell under the brand name Casgevy in the UK for two blood diseases.

Via Investor's Business Daily

What's Going On With Crispr Therapeutics Stock Thursday? ↗

November 16, 2023

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.